References

1. Falkai, P; Wobrock, T; Lieberman, J.; Glenthoj, B.; Gattaz, W F; Moller, H. J. World J. Biol. Psychiat. 2005, 6, 132-191. 2 . Carpenter, W T ; Conley, R. R. ; Buchanan, R. W In Pharmacological Management of Neurological and Psychiatric Disorders; Enna, S . J . , Coyle, J . T , Eds.; McGraw-Hill: New York, 1998, pp 27-51.

3. Deniker, P In Discoveries in Pharmacology: Vol. 1, Psycho- and Neuro-Pharmacology; Parnham, M. J., Bruinvels, J., Eds.; Elsevier: Amsterdam, the Netherlands, 1983, pp 163-180.

4. First, M. B.; Tasman, A. In DSM-IV-TR Mental Disorders: Diagnosis, Etiology and Treatment; John Wiley: Chichester, UK, 2004, pp 639-701.

5. McGurk, S. R. J. Psychiatr. Pract. 2000, 6, 190-196.

6. Marder, S. R.; Fenton, W Schizophr. Res. 2004, 72, 5-9.

7. Petronis, A. Biol. Psychiatry 2004, 55, 965-970.

8. Krabbendam, L.; Van Os, J. Schizophr. Bull. 2005, 31, 795-799.

9. Charlton, B. G. Med. Hypotheses 2005, 65, 1005-1009.

10. Lewis, D. A.; Lieberman, J. A. Neuron 2000, 28, 325-334.

11. Gaddum, J. H.; Hameed, K. A. Br. J. Pharmacol. Chemother. 1954, 9, 240-248.

12. Meltzer, H. Y Neuropsychopharmacology 1999, 21, 106S-115S.

13. Coyle, J. T. Harv. Rev. Psychiatry 1996, 3, 241-253.

14. Millan, M. J. Curr. Drug Targets. CNS Neurol. Disord. 2002, 1, 191-213.

15. Moghaddam, B.; Adams, B.; Verma, A.; Daly, D. J. Neurosci. 1997, 17, 2921-2927.

16. Aghajanian, G. K.; Marek, G. J. Brain Res. 1999, 825, 161-171.

17. Taylor, C. P. Drug Dev. Res. 1990, 21, 151-160.

18. Wassef, A.; Baker, J.; Kochan, L. D. J. Clin. Psychopharmacol. 2003, 23, 601-640.

19. Benes, F M. Brain Res. Brain Res. Rev. 2000, 31, 251-269.

20. Wahlbeck, K.; Cheine, M.; Essali, M. A. Cochrane Database Syst. Rev. 2000, CD000059.

21. Bagnall, A. M.; Jones, L.; Ginnelly, L.; Lewis, R.; Glanville, J.; Gilbody, S.; Davies, L.; Torgerson, D.; Kleijnen, J. Health Technol. Assess. 2003, 7, 1-193.

22. Roth, B. L.; Sheffler, D. J.; Kroeze, W K. Nat. Rev. Drug Disc. 2004, 3, 353-359.

23. Davies, M. A.; Compton-Toth, B. A.; Hufeisen, S. J.; Meltzer, H. Y; Roth, B. L. Psychopharmacology 2005, 178, 451-460.

24. Kendler, K. S. Am. J. Psychiatry 2003, 160, 1549-1553.

25. Takahashi, S.; Faraone, S. V; Lasky-Su, J.; Tsuang, M. T Psychiatr. Res. 2005, 133, 111-122.

26. Owen, M. J.; Craddock, N.; O'Donovan, M. C. Trends Genet. 2005, 21, 518-525.

27. Williams, M. Curr. Opin. Investig Drugs 2003, 4, 31-36.

28. Tunbridge, E. M.; Harrison, P. J.; Weinberger, D. R. Biol. Psychiatry 2006, 60, 141-151.

29. Funke, B.; Malhotra, A. K.; Finn, C. T.; Plocik, A. M.; Lake, S. L.; Lencz, T.; DeRosse, P.; Kane, J. M.; Kucherlapati, R. Behav. Brain Funct. 2005, 1, 19.

30. Harrison, P. J.; Law, A. J. Biol. Psychiatry 2006, 60, 132-140.

31. Duan, J.; Martinez, M.; Sanders, A. R.; Hou, C.; Krasner, A. J.; Schwartz, D. B.; Gejman, P V Psychol. Med. 2005, 35, 1599-1610.

32. Talkowski, M. E.; Chowdari, K. V; Lewis, D. A.; Nimgaonkar, V L. Schizophr. Bull. 2006, 32, 203-208.

33. Chumakov, I.; Blumenfeld, M.; Guerassimenko, O.; Cavarec, L.; Palicio, M.; Abderrahim, H.; Bougueleret, L.; Barry, C.; Tanaka, H.; La Rosa P et al. Proc. Natl. Acad. Sci. USA 2002, 99, 13675-13680.

34. Ma, J.; Qin, W; Wang, X. Y; Guo, T W; Bian, L.; Duan, S. W; Li, X. W; Zou, F G.; Fang, Y R.; Fang, J. X. et al. Mol. Psychiatry 2006, 11, 479-487.

35. Schumacher, J.; Jamra, R. A.; Freudenberg, J.; Becker, T.; Ohlraun, S.; Otte, A. C.; Tullius, M.; Kovalenko, S.; Bogaert, A. V; Maier, W et al. Mol. Psychiatry 2004, 9, 203-207.

36. Zhao, X.; Li, H.; Shi, Y; Tang, R.; Chen, W; Liu, J.; Feng, G.; Shi, J.; Yan, L.; Liu, H.; He, L. Biol. Psychiatry 2006, 59, 747-753.

37. Mohn, A. R.; Gainetdinov, R. R.; Caron, M. G.; Koller, B. H. Cell 1999, 98, 427-436.

38. Kamiya, A.; Kubo, K.; Tomoda, T; Takaki, M.; Youn, R.; Ozeki, Y; Sawamura, N.; Park, U.; Kudo, C.; Okawa, M. et al. Nat. Cell Biol. 2005, 7, 1067-1078.

39. Freedman, R.; Adler, L. E.; Leonard, S. Biol. Psychiatry 1999, 45, 551-558.

40. Staddon, S.; Arranz, M. J.; Mancama, D.; Perez-Nievas, F; Arrizabalaga, I.; Anney, R.; Buckland, P; Elkin, A.; Osborne, S.; Munro, J. et al. Schizophr. Res. 2005, 73, 49-54.

41. Koob, G. F; Simon, H.; Herman, J. P.; Le Moal, M. Brain Res. 1984, 303, 319-329.

42. Weiner, I. Psychopharmacology 2003, 169, 257-297.

43. Ford, J. M. Psychophysiology 1999, 36, 667-682.

44. Louchart-de la Chapelle, S.; Levillain, D.; Menard, J. F; Van der Elst, A.; Allio, G.; Haouzir, S.; Dollfus, S.; Campion, D.; Thibaut, F Psychiatry Res. 2005, 136, 27-34.

45. Braff, D. L.; Grillon, C.; Geyer, M. A. Arch. Gen. Psychiatry 1992, 49, 206-215.

46. Grillon, C.; Ameli, R.; Charney, D. S.; Krystal, J.; Braff, D. Biol. Psychiatry 1992, 32, 939-943.

47. Geyer, M. A.; Krebs-Thomson, K.; Braff, D. L.; Swerdlow, N. R. Psychopharmacology 2001, 156, 117-154.

48. Glantz, L. A.; Gilmore, J. H.; Lieberman, J. A.; Jarskog, L. F Schizophr. Res. 2006, 81, 47-63.

49. Lipska, B. K.; Jaskiw, G. E.; Weinberger, D. R. Neuropsychopharmacology 1993, 9, 67-75.

50. Van den Buuse, M.; Garner, B.; Koch, M. Curr. Mol. Med. 2003, 3, 459-471.

51. Peters, Y M.; O'Donnell, P. Biol. Psychiatry 2005, 57, 1205-1208.

52. Stroup, T S.; Alves, W M.; Hamer, R. M.; Lieberman, J. M. Nat. Rev. Drug Disc. 2005, 5, 107-114.

53. Creese, I.; Burt, D. R.; Snyder, S. H. Science 1976, 192, 481-483.

54. Seeman, P; Lee, T Science 1975, 188, 1217-1219.

55. Lieberman, J. A.; Stroup, T S.; McEvoy, J. P.; Swartz, M. S.; Rosenheck, R. A.; Perkins, D. O.; Keefe, R. S.; Davis, S. M.; Davis, C. E.; Lebowitz, B. D. et al. N. Engl. J. Med. 2005, 353, 1209-1223.

56. Kessler, R. M.; Ansari, M. S.; Riccardi, P; Li, R.; Jayathilake, K.; Dawant, B.; Meitzer, H. Y Neuropsychopharmacology 2005, 30, 2283-2289.

57. Poyurovsky, M.; Epshtein, S.; Fuchs, C.; Schneidman, M.; Weizman, R.; Weizman, A. J. Clin. Psychopharmacol. 2003, 23, 305-308.

58. Hirose, T.; Kikuchi, T J. Med. Invest. 2005, 52, 284-290.

59. Glassman, A. H.; Bigger, J. T, Jr. Am. J. Psychiatry 2001, 158, 1774-1782.

60. Straus, S. M.; Bleumink, G. S.; Dieleman, J. P; van der Lei, J.; 't Jong, G. W; Kingma, J. H.; Sturkenboom, M. C.; Stricker, B. H. Arch. Intern. Med. 2004, 164, 1293-1297.

61. Newcomer, J. W J. Clin. Psychiatry 2004, 65, 36-46.

62. Meyer, J.; Koro, C. E.; LItalien, G. J. Int. Rev Psychiatry 2005, 17, 173-180.

63. Lindenmayer, J. P.; Czobor, P.; Volavka, J.; Citrome, L.; Sheitman, B.; McEvoy, J. P; Cooper, T. B.; Chakos, M.; Lieberman, J. A. Am. J. Psychiatry 2003, 160, 290-296.

64. Simard, M.; van Reekum, R. J. Neuropsychiat. Clin. Neurosci. 2004, 16, 409-425.

65. Sur, C.; Mallorga, P. J.; Wittmann, M.; Jacobson, M. A.; Pascarella, D.; Williams, J. B.; Brandish, P E.; Pettibone, D. J.; Scolnick, E. M.; Conn, P J. Proc. Natl. Acad. Sci. USA 2003, 100, 13674-13679.

66. Weiner, D. M.; Meltzer, H. Y; Veinbergs, I.; Donohue, E. M.; Spalding, T A.; Smith, T. T; Mohell, N.; Harvey, S. C.; Lameh, J.; Nash, N. et al. Psychopharmacology 2004, 177, 207-216.

67. Javitt, D. C. Curr. Opin. Investig. Drugs 2002, 3, 1067-1072.

68. Chavez-Noriega, L. E.; Schaffhauser, H.; Campbell, U. C. Curr. Drug Targets CNS Neurol. Disord. 2002, 1, 261-281.

69. Kinney, G. G.; O'Brien, J. A.; Lemaire, W; Burno, M.; Bickel, D. J.; Clements, M. K.; Chen, T. B.; Wisnoski, D. D.; Lindsley, C. W; Tiller, P R. et al. J. Pharmacol. Exp. Ther. 2005, 313, 199-206.

70. Wroblewska, B.; Wroblewski, J. T; Pshenichkin, S.; Surin, A.; Sullivan, S. E.; Neale, J. H. J. Neurochem. 1997, 69, 174-181.

71. Zhou, J.; Neale, J. H.; Pomper, M. G.; Kozikowski, A. P Nat. Rev Drug Disc. 2005, 4, 1015-1026.

72. deHaan, L.; Booij, J.; Lavalaye, J.; van Amelsvoort, T.; Linszen, D. Psychopharmacology 2006, 183, 500-505.

73. Martin, L. F; Kem, W R.; Freedman, R. Psychopharmacology 2004, 174, 54-64.

74. Spooren, W; Riemer, C.; Meltzer, H. Nat. Rev Drug Disc. 2005, 4, 967-975.

75. Spedding, M.; Jay, T; Costa e Silva, J.; Perret, L. Nat. Rev. Drug Disc. 2005, 4, 467-476.

76. Insel, T R.; Scolnick, E. M. Mol. Psychiatry 2006, 11, 11-17.

77. Santarelli, L.; Saxe, M.; Gross, C.; Surget, A.; Battaglia, F; Dulawa, S.; Weisstaub, N.; Lee, J.; Duman, R.; Arancio, O. et al. Science 2003, 301, 805-809.

78. Kippin, T E.; Kapur, S.; Van Der Kooy, D. J. Neurosci. 2005, 25, 5815-5823.

79. Bodick, N. C.; Offen, W. W.; Levey, A. I.; Cutler, N. R.; Gauthier, S. G.; Satlin, A.; Shannon, H. E.; Tollefson, G. D.; Rasmussen, K.; Bymaster, F P et al. Arch. Neurol. 1997, 54, 465-473.

80. Jones, P B.; Buckley, P F Schizophrenia; Lundbeck Institute: Skodsborg, Denmark, 2006.

81. Eaton, W. W; Byrne, M.; Ewald, H.; Mors, O.; Chen, C.-Y; Agerbo, E.; Preben Bo Mortensen, P B. Am. J. Psychiatry 2006, 163, 521-528.

82. Zubieta, J.-K.; Heitzeg, M. M.; Smith, Y R.; Bueller, J. A.; Xu, K.; Xu, Y; Koeppe, R. A.; Stohler, C. S.; Goldman, D. Science 2003, 299, 1240-1243.

83. Wu, A. H.; Tseng, C. C.; Van Den Berg, D.; Yu, M. C. Cancer Res. 2003, 63, 7526-7529.

84. Brown, S.; Birtwistle, J.; Roe, L.; Thompson, C. Psychol. Med. 1999, 29, 697-701.

85. Casey, D. E.; Hansen, T. E. In Medical Illness and Schizophrenia; Meyer, J. M., Nasrallah, H. A., Eds.; Am. Psychiatr. Publ.: Washington, DC, 2003, pp 13-34.

86. Kroeze, W. K.; Hufeisen, S. J.; Popadak, B. A.; Renock, S. M.; Steinberg, S.; Ernsberger, P; Jayathilake, K.; Meltzer, H. Y; Roth, B. L.

Neuropsychopharmacology 2003, 28, 519-526.

Diabetes Sustenance

Diabetes Sustenance

Get All The Support And Guidance You Need To Be A Success At Dealing With Diabetes The Healthy Way. This Book Is One Of The Most Valuable Resources In The World When It Comes To Learning How Nutritional Supplements Can Control Sugar Levels.

Get My Free Ebook


Post a comment